Literature DB >> 28931128

6-year review of +Redivi: a prospective registry of imported infectious diseases in Spain.

José A Pérez-Molina1, Ana López-Polín1, Begoña Treviño2, Israel Molina3, Josune Goikoetxea4, Marta Díaz-Menéndez5, Diego Torrús6, Eva Calabuig7, Agustín Benito8, Rogelio López-Vélez1.   

Abstract

Background: Understanding and detecting imported diseases is a priority in the prevention and management of prevalent and emergent infectious diseases acquired abroad. The +Redivi network measures the burden of imported infections in Spain and is essential for closing the gap in travel medicine.
Methods: Demographic characteristics, travel information, syndromes and confirmed travel-related diagnoses were registered in a standardised online database.
Results: A total of 10 767 cases of imported infectious diseases were registered between October 2009 and December 2015. Of these, 60.8% of cases were immigrants seen for the first time after arrival, 20.6% were travellers, and 18.4% were individuals visiting friends and relatives (VFR [immigrants and travellers]). The median time between arrival and medical consultation was 5.5 years for immigrants, 2.0 weeks for travellers, 3.1 weeks for VFR-travellers and 11.4 for VFR-immigrants. The most prevalent diagnoses were Chagas disease in immigrants and nonspecific acute diarrhoea in travellers. Malaria by P. falciparum was one of the most prevalent diagnoses among VFR. More than half the travellers saw a physician before travelling, although one-third of those for whom antimalarial medication was indicated did not take their medication correctly. As for VFR, only 10.4% of VFR-immigrants and 32.5% of VFR-travellers sought pre-travel advice. Only 23 and 21%, respectively, of those for whom antimalarial prophylaxis was indicated took the medication properly. Conclusions: +Redivi provides a clear picture of the prevalence of imported infectious diseases among travellers and immigrants in Spain. The data collected could be used to improve everyday health care provided to travellers and immigrants after travel, to guide pre-travel consultations and to monitor the potential occurrence of tropical or exotic infectious diseases. © International Society of Travel Medicine, 2017. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com

Entities:  

Keywords:  +Redivi; Traveller; migrants; network; travel

Mesh:

Year:  2017        PMID: 28931128     DOI: 10.1093/jtm/tax035

Source DB:  PubMed          Journal:  J Travel Med        ISSN: 1195-1982            Impact factor:   8.490


  9 in total

1.  A Prospective Study on the Impact and Out-of-Pocket Costs of Dengue Illness in International Travelers.

Authors:  Yesim Tozan; Tyler Y Headley; Maquines Odhiambo Sewe; Eli Schwartz; Tamar Shemesh; Jakob P Cramer; Kirsten A Eberhardt; Michael Ramharter; Nicole Harrison; Karin Leder; Andrea Angheben; Christoph Hatz; Andreas Neumayr; Lin Hwei Chen; Cornelis A De Pijper; Martin P Grobusch; Annelies Wilder-Smith
Journal:  Am J Trop Med Hyg       Date:  2019-06       Impact factor: 2.345

2.  Usefulness of Malachite-Green LAMP for Diagnosis of Plasmodium and Five Human Malaria Species in a Nonendemic Setting.

Authors:  Alexandra Martín Ramírez; Marta Lanza Suárez; Carlota Muñoz García; Shamilah R Hisam; Ana Perez-Ayala; José M Rubio
Journal:  Am J Trop Med Hyg       Date:  2022-03-14       Impact factor: 3.707

3.  Imported strongyloidiasis: Data from 1245 cases registered in the +REDIVI Spanish Collaborative Network (2009-2017).

Authors:  Fernando Salvador; Begoña Treviño; Sandra Chamorro-Tojeiro; Adrián Sánchez-Montalvá; Juan María Herrero-Martínez; Azucena Rodríguez-Guardado; Núria Serre-Delcor; Diego Torrús; Josune Goikoetxea; Zuriñe Zubero; María Velasco; Elena Sulleiro; Israel Molina; Rogelio López-Vélez; José Antonio Pérez-Molina
Journal:  PLoS Negl Trop Dis       Date:  2019-05-16

4.  Screening for Trypanosoma cruzi infection in immigrants and refugees: Systematic review and recommendations from the Spanish Society of Infectious Diseases and Clinical Microbiology.

Authors:  María Velasco; Luis Andrés Gimeno-Feliú; Israel Molina; Joaquín Salas-Coronas; Ivan Solà; Begoña Monge-Maillo; Diego Torrús-Tendero; Joan Caylà; Ena Niño de Guzmán; Jl Pérez Arellano; Jose A Pérez-Molina
Journal:  Euro Surveill       Date:  2020-02

Review 5.  European expert network on rare communicable diseases and other rare diseases linked to mobility and globalisation focused on health care provision (EURaDMoG): a feasibility study.

Authors:  Ana Requena-Méndez; Zeno Bisoffi; Joan-Lluis Vives-Corrons; Joaquim Gascon; Antoni Plasència
Journal:  Orphanet J Rare Dis       Date:  2020-10-16       Impact factor: 4.123

6.  Does International Travel Frequency Affect COVID-19 Biosecurity Behavior in the United States?

Authors:  Myung Ja Kim; C Michael Hall; Mark Bonn
Journal:  Int J Environ Res Public Health       Date:  2021-04-13       Impact factor: 3.390

7.  High prevalence of malaria in a non-endemic setting among febrile episodes in travellers and migrants coming from endemic areas: a retrospective analysis of a 2013-2018 cohort.

Authors:  Alejandro Garcia-Ruiz de Morales; Covadonga Morcate; Elena Isaba-Ares; Ramon Perez-Tanoira; Jose A Perez-Molina
Journal:  Malar J       Date:  2021-11-27       Impact factor: 2.979

8.  Cost-effectiveness of different strategies for screening and treatment of Strongyloides stercoralis in migrants from endemic countries to the European Union.

Authors:  Philip Erick Wikman-Jorgensen; Jara Llenas-Garcia; Jad Shedrawy; Joaquim Gascon; Jose Muñoz; Zeno Bisoffi; Ana Requena-Mendez
Journal:  BMJ Glob Health       Date:  2020-05

9.  Fake imported tropical diseases: A retrospective study.

Authors:  M Belhassen-García; J L Pérez-Arellano; A Romero-Alegría; M Hernandez Cabrera; V Velasco-Tirado; E Pisos Álamo; J Pardo-Lledías; N Jaén Sánchez
Journal:  Rev Esp Quimioter       Date:  2018-10-22       Impact factor: 1.553

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.